Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic

Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International urology and nephrology 2022, Vol.54 (2), p.459-460
Hauptverfasser: Tatar, Erhan, Erdi, Zuleyha Can, Ozgur, Oyku, Tasdemir, Anıl, Tatar, Bengu
Format: Report
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 460
container_issue 2
container_start_page 459
container_title International urology and nephrology
container_volume 54
creator Tatar, Erhan
Erdi, Zuleyha Can
Ozgur, Oyku
Tasdemir, Anıl
Tatar, Bengu
description
doi_str_mv 10.1007/s11255-021-02890-y
format Report
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2528823104</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2528823104</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_25288231043</originalsourceid><addsrcrecordid>eNqVyrtOAzEQhWELCYmE8AJUU9IYxt5YcUoUBUFLorSR8U6IkS-LL8Xy9CxSXoDi6C_Ox9i9wEeBuHoqQkilOEoxTa-Rj1dsJtSq41Lp5Q2bl_KFiGuNOGPtLQwpVxMtQToB2ebdTwvmA2omUwPFCi5Cno6c6aJMHQdnjYczheTH6iy0TGFKGWOfUyDoW3bxE-qZYPf8vuObdOASBhP7P7dg1yfjC91desseXrb7zSsfcvpuVOoxuGLJexMptXKUSmotO4HL7h_0FzDCVeA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>2528823104</pqid></control><display><type>report</type><title>Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic</title><source>SpringerLink Journals - AutoHoldings</source><creator>Tatar, Erhan ; Erdi, Zuleyha Can ; Ozgur, Oyku ; Tasdemir, Anıl ; Tatar, Bengu</creator><creatorcontrib>Tatar, Erhan ; Erdi, Zuleyha Can ; Ozgur, Oyku ; Tasdemir, Anıl ; Tatar, Bengu</creatorcontrib><identifier>EISSN: 1573-2584</identifier><identifier>DOI: 10.1007/s11255-021-02890-y</identifier><language>eng</language><ispartof>International urology and nephrology, 2022, Vol.54 (2), p.459-460</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,780,4475,27904</link.rule.ids></links><search><creatorcontrib>Tatar, Erhan</creatorcontrib><creatorcontrib>Erdi, Zuleyha Can</creatorcontrib><creatorcontrib>Ozgur, Oyku</creatorcontrib><creatorcontrib>Tasdemir, Anıl</creatorcontrib><creatorcontrib>Tatar, Bengu</creatorcontrib><title>Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic</title><title>International urology and nephrology</title><issn>1573-2584</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2022</creationdate><recordtype>report</recordtype><recordid>eNqVyrtOAzEQhWELCYmE8AJUU9IYxt5YcUoUBUFLorSR8U6IkS-LL8Xy9CxSXoDi6C_Ox9i9wEeBuHoqQkilOEoxTa-Rj1dsJtSq41Lp5Q2bl_KFiGuNOGPtLQwpVxMtQToB2ebdTwvmA2omUwPFCi5Cno6c6aJMHQdnjYczheTH6iy0TGFKGWOfUyDoW3bxE-qZYPf8vuObdOASBhP7P7dg1yfjC91desseXrb7zSsfcvpuVOoxuGLJexMptXKUSmotO4HL7h_0FzDCVeA</recordid><startdate>20220201</startdate><enddate>20220201</enddate><creator>Tatar, Erhan</creator><creator>Erdi, Zuleyha Can</creator><creator>Ozgur, Oyku</creator><creator>Tasdemir, Anıl</creator><creator>Tatar, Bengu</creator><scope>7X8</scope></search><sort><creationdate>20220201</creationdate><title>Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic</title><author>Tatar, Erhan ; Erdi, Zuleyha Can ; Ozgur, Oyku ; Tasdemir, Anıl ; Tatar, Bengu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_25288231043</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Tatar, Erhan</creatorcontrib><creatorcontrib>Erdi, Zuleyha Can</creatorcontrib><creatorcontrib>Ozgur, Oyku</creatorcontrib><creatorcontrib>Tasdemir, Anıl</creatorcontrib><creatorcontrib>Tatar, Bengu</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tatar, Erhan</au><au>Erdi, Zuleyha Can</au><au>Ozgur, Oyku</au><au>Tasdemir, Anıl</au><au>Tatar, Bengu</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic</atitle><jtitle>International urology and nephrology</jtitle><date>2022-02-01</date><risdate>2022</risdate><volume>54</volume><issue>2</issue><spage>459</spage><epage>460</epage><pages>459-460</pages><eissn>1573-2584</eissn><doi>10.1007/s11255-021-02890-y</doi></addata></record>
fulltext fulltext
identifier EISSN: 1573-2584
ispartof International urology and nephrology, 2022, Vol.54 (2), p.459-460
issn 1573-2584
language eng
recordid cdi_proquest_miscellaneous_2528823104
source SpringerLink Journals - AutoHoldings
title Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T04%3A35%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Importance%20of%20eculizumab%20treatment%20in%20recurrence%20of%20atypical%20hemolytic%20uremic%20syndrome%20during%20the%20SARS-CoV-2%20pandemic&rft.jtitle=International%20urology%20and%20nephrology&rft.au=Tatar,%20Erhan&rft.date=2022-02-01&rft.volume=54&rft.issue=2&rft.spage=459&rft.epage=460&rft.pages=459-460&rft.eissn=1573-2584&rft_id=info:doi/10.1007/s11255-021-02890-y&rft_dat=%3Cproquest%3E2528823104%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2528823104&rft_id=info:pmid/&rfr_iscdi=true